Nektar Therapeutics reported $412.22M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US USD 1.05B 73.9M
Amgen AMGN:US USD 3.65B 1.23B
Astrazeneca AZN:US USD 35.13B 798M
Baxter International BAX:US USD 5.54B 3.32B
Biocryst Pharmaceuticals BCRX:US USD -242659000 29.43M
Biogen BIIB:US USD 12.78B 903M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Cara Therapeutics CARA:US USD 184.82M 19.6M
Eisai 4523:JP JPY 828.13B 23.58B
Eli Lilly And LLY:US USD 10.07B 1.53B
Esperion Therapeutics ESPR:US USD -294100000 2.4M
Exelixis EXEL:US USD 2.49B 100.14M
Gilead Sciences GILD:US USD 21.06B 821M
GlaxoSmithKline GSK:LN GBP 9.15B 7.22B
Halozyme Therapeutics HALO:US USD 96.99M 196.18M
Immunogen IMGN:US USD 178.01M 71.82M
Ironwood Pharmaceuticals IRWD:US USD 591.06M 58.18M
Karyopharm Therapeutics KPTI:US USD -140280000 23.94M
Macrogenics MGNX:US USD 122.96M 19.52M
Mirati Therapeutics MRTX:US USD 1.13B 17.05M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Novartis NOVN:VX USD 60.82B 2.1B
Roche Holding ROG:VX 25.19B 700M
Sarepta Therapeutics SRPT:US USD 430.84M 295.62M
Seattle Genetics SGEN:US USD 2.82B 111M
Takeda 4502:JP JPY 6.71T 396.1B
Teva Pharmaceutical TEVA:IT USD 8.77B 269M
Xencor XNCR:US USD 722.7M 19.64M
YTE INCY:US USD 4.23B 141.59M